XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2022
Share-based Compensation  
Summary of non-vested restricted stock awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Average Grant-date

​

Aggregate

(In thousands, except for weighted average price data)

    

Awards

    

Fair Value

    

Intrinsic Value

Non-vested at June 30, 2022

 

1,355

​

$

5.28

​

​

​

Granted

 

—

​

 

—

​

​

​

Vested

 

(549)

​

 

5.46

​

$

317

Forfeited

 

(22)

​

 

5.00

​

​

​

Non-vested at September 30, 2022

 

784

​

$

5.17

​

​

​

​

Schedule of allocation of share-based compensation

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

​

September 30, 

​

(In thousands)

    

2022

    

2021

​

Selling, general and administrative expenses

​

$

1,444

​

$

2,697

​

Research and development expenses

​

 

28

​

 

95

​

Cost of sales

​

 

107

​

 

226

​

Total

​

$

1,579

​

$

3,018

​

​

​

​

​

​

​

​

​

Tax benefit at statutory rate

​

$

355

​

$

679

​